In 1998 Dr. Rick Shinto laid the ground work for the foundation of InnovaCare Health. Dr. Shinto was a practicing physician and joined the North American Medical Management in California. He wanted to provide quality care that was also efficient so he decided that working with the North American Medical Management would help provide efficient health care solutions to patients.
2003 marked a year of change for the North American Medical Management team when they joined with the Straus Group. The Straus Group was founded by Daniel Straus and he held a position as a Chairman of the Board during the growth of this new merger. For 8 years the Strause Group continued to grow throughout North America and Puerto Rico. In 2012 InnovaCare health was officially founded and began working with Medicaid plans throughout the United States.
Dr. Rick Shinto is the President and CEO of InnovaCare. He has more than twenty years of clinical experience that includes operational and managed health care. In 2017 Dr. Shinto was honored to be elected to sit on the board of directors for AHIP which is one of the largest trade solutions within the healthcare industry. Dr. Rick earned his bachelor’s degree from the University of California in Irvine and his medical degree from the State University of New York that is located at Stony Brook. Dr. Shinto continued his education and earned his master’s degree from the University of Redlands. In 2012 Dr. Rick Shinto won the prestigious Ernest & Young Entrepreneur of the Year award in the Service category. This award is given to individuals who show extraordinary success in the field of innovation.
Innovacare Health is staffed with health care professionals who care about patients and their health management. In addition to Dr. Rick Shinto, Innovacare also has Penelope Kokkinides as their Chief Administrative Officer. She joined Innovacare in 2015 in this role. Previously Penelope served as the vice president and Chief Operating Officer of Aveta Inc. She has more than twenty years of health care experience that deal with government programs such as Medicaid and Medicare. Having expertise in these government programs provides vast knowledge of treatment options and coverage for Innovacare Health patients. Penelope earned her bachelor’s degree in biological sciences and classical languages from Binghamton University. She continued her education at New York University and earned a master’s degree in social work. Innovacare has come a long way since its ground work was established back in 1998 with Dr. Shinto’s belief that healthcare and management needed to be more efficiently operated. Employing a highly effective executive staff continually results in maintaining Innovacare as a industry leader.
Men are rarely known for multitasking. However, the few who can pull it off do so in quite a remarkable way. One Mark Holterman is the best example of a man with an immense capability to multitask. Mark is known to hold numerous different job occupations at a time throughout his life. From being a university professor to a pediatric surgeon, medical researcher and a general physician and investor, Dr. Mark Holterman is one with multiple talents and dedication.
Dr. Mark Holterman is a former Illinois University professor and a current professor at the Medical College at Peoria Illinois. He is also a well-known pediatric surgeon working at the Illinois Children’s Hospital OSF and continually lends a helping hand to several other hospitals in the Chicago environs when it comes to children medical cases. Mark is also the head of the Mariam Global Health Organization which focuses on beginner pharmaceutical companies with outstanding potential and funds these companies. In addition to financially giving them a boost in their startup, Miriam Global Health also provides the companies with skilled managerial support (Twitter). With his kind of support, Mark Holterman intends on finding investors for them and helping them increase their growth rate in order to maintain investors and in return prosper and lead to growth in the health sector.
Other than Mariam Global Health, Mark has also been involved in the establishment of several medical research funding agencies over the years. He specifically invested in research that is aimed at discovering new treatment for stem cell-related illnesses. Diabetes is also an area of interest for Dr. Mark Holterman. However, his greatest passion up to date is helping children. He is the head financier and organizer of the International Specialist Alliance for Children in Vietnam.
For all these works, the Wisconsin born doctor has been able to receive awards like the A.D.A’S Innovative Research Award in 2001, the Patient’s Choice award which he won for three consecutive years and the seven-time top rank of America’s Top Doctor by the medical research company, Castle Connolly. Mark Holterman received his medical degree from the University of Virginia and since then has been involved with the healthcare industry for two decades.
EX#1: Visit Dr. Mark Holterman on Twitter
EX:#2 For more information about Dr. Mark Holterman visit http://peoria.medicine.uic.edu/departments/surgery/surgery-faculty/name/mark-holterman/
Amicus Therapeutics is a biotechnological company recognized globally for their dedication towards the treatment of orphan diseases. The company has been at the forefront of research and treatment of a range of devastating rare diseases.
Amicus Therapeutics was founded in February 2002 and is based in Cranbury, New Jersey. The company is headed by John Crowley, who is the CEO and Chairman of the board. Other key figures include Bradley Campbell, who is the Chief Operations Officer, and William Baird, who is the Chief Finance Officer. Amicus Therapeutics is a publicly traded company under the brand NASDAQ. The company has been on the stock exchange since 2007 after a planned IPO.
Amicus mainly focuses on rare and orphan diseases (http://www.phillypurge.com/2017/08/02/amicus-therapeutics-the-fight-against-the-rare-diseases/). The Chaperone-Advanced Replacement Therapy, otherwise referred to as CHART is the main basis of the company’s product development. Amicus has put an emphasis on enzyme replacement therapies (ERTs). The company’s efforts have earned them accolades. In 2014, Amicus was recognized as the company with the broadest portfolio in terms of small molecule pharmacological chaperones in the entire pharmaceutical industry.
Although they had no marketed products by February 2014, some of the most notable developments from Amicus Therapeutics include migalastat, otherwise known as Galafold. Galafold is a pharmacological chaperone treatment which is aimed at stabilizing endogenous mutant alpha-galactosidase for the treatment of Fabry disease.
Amicus Therapeutics has no manufacturing capabilities and therefore relies on contract manufacturing (WeeklyOpinion). Additionally, the company collaborates with other like-minded firms to come up with treatments for complex diseases. One of its most notable collaborations was with GlaxoSmithKline and JCR Pharmaceutical. The collaboration which lasted from 2010 to 2013 was aimed at investigating co-formulation with recombinant alpha-galactosidase.
It is worth noting that in 2008, the company expanded its activities from its single location in New Jersey to a second research facility in San Diego. Additionally, Amicus got a big financial boost, when they received a US$500,000 grant in 2010 from the Michael J. Fox Foundation. The grant was aimed at supporting studies conducted by Amicus in collaboration with the David Geffen School of Medicine.
In 2013, Amicus went a step further and acquired CallidusBiopharma, which was one of their competitors. The acquisition granted Amicus Therapeutics intellectual and material property for the treatment of Pompe disease.
Osteoarthritis is described by the wearing out of cartilage, the soft tissue situated between the joints. As cartilage breaks down and wears away, the body bones rub against each other causing pain, stiffness and swelling. After some time, joints lose energy and pain may become very high. While there is no cure, there are many treatment alternatives available for handling joint pain and ensuring that one lives a good life.
Effects associated with osteoarthritis include weight, age, family history and previous exposure. Since osteoarthritis is non-curable and degenerative, a patient’s commitment to self-management is enough to minimize the scope and speed of the condition’s impact. There are a few components of arthritis self-management, in a perfect world used in combination for most desired success and relief.
There are different treatments available for arthritis pain relief. However, all medications involve some danger of developing side effects over a long-term use. It is good that you chat with your doctor about acetaminophen or topical analgesics, to know what might work best for you (HealthGrades). A qualified Physical Therapy professional is an amazing asset to enable you to figure out how to move and deal with your body to limit the pain and portability loss related to arthritis. Finally, when more conservative techniques have failed, a patient may get life from undergoing surgery. Alternatives include joint fusion, minimal obtrusive joint repair, and joint replacements.
If you need the above services, Osteo Relief Institute is the best place to go (https://yourbeautycraze.com/osteo-relief-institute-offers-hope-arthritis-sufferers/). It is located in NJ, 1985 State Route 34 Ste A8, and Wall Township, NJ 07719. This is one place where you will get quality joint injection services. Note that joint injections are intended to decrease pain symptoms to such an extent that patients can take an interest in active recuperation practice and ordinary exercises keeping in mind the end goal to stretch and strengthen the joint. Our orthopedic authority can also confirm your determination when giving a joint injection. The pro will pick from the lower leg, metatarsophalangeal and subtalar joints which are the common joints for injections. We also have an ultrasound machine which is used to direct the injection into that joint.
More about Osteo Relief Institute on Crunchbase